156
Views
3
CrossRef citations to date
0
Altmetric
Solid Tumors and Neurooncology

Treatment challenges and outcomes for pediatric intracranial ependymoma at a single institution in Iran

, , , , , , , , , & show all
Pages 60-75 | Received 07 Mar 2017, Accepted 19 Jan 2018, Published online: 22 Mar 2018

References

  • Pejavar S, Polley MY, Rosenberg-Wohl S, et al. Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy. J Neurooncol. 2012;106(2):367–375. doi:10.1007/s11060-011-0671-9. PMID: 21826561.
  • Lin FY, Chintagumpala M. Advances in management of pediatric ependymomas. Curr Oncol Rep. 2015;17(10):47. doi:10.1007/s11912-015-0470-0. PMID: 26369328.
  • Merchant TE, Li C, Xiong X, et al. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. Lancet Oncol. 2009;10(3):258–266. doi:10.1016/S1470-2045(08)70342-5. PMID: 19274783.
  • Garvin JH Jr, Selch MT, Holmes E, et al. Phase II study of pre‐irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2012;59(7):1183–1189. doi:10.1002/pbc.24274. PMID: 22949057.
  • Boström A, Boström J, Hartmann W, et al. Treatment results in patients with intracranial ependymomas. Cent Eur Neurosurg. 2011;72(3):127–132. doi:10.1055/s-0031-1273745. PMID: 21630189.
  • Chan MH, Boop F, Qaddoumi I. Challenges and opportunities to advance pediatric neuro-oncology care in the developing world. Childs Nerv Syst. 31(8):1227–1237. doi:10.1007/s00381-015-2771-x. PMID: 26040936.
  • Liu AP, Shing MM, Yuen HL, et al. Timing of adjuvant radiotherapy and treatment outcome in childhood ependymoma. Pediatr Blood Cancer. 2014;61(4):606–611. doi:10.1002/pbc.24820. PMID: 24167035.
  • El-Gaidi MA, Eissa EM. Infantile intracranial neoplasms: characteristics and surgical outcomes of a contemporary series of 21 cases in an Egyptian referral center. Pediatr Neurosurg. 46(4):272–282. doi:10.1159/000321540. PMID: 21160236.
  • Mehrvar N, Mehrvar A, Akbari ME, et al. Comprehensive analysis of Iranian reports of pediatric central nervous system tumors. Child's Nervous Syst. 2017;33(9):1481–1490.
  • Samad A, Daneshbod K. Soft tissue ependymoma in the sacrococcygeal region. Iran J Surg. 1980;3:243–247.
  • Ansari SH, Vosough P, Mo'udi S. Determination of the main epidemiological factors in children with brain tumor admitted to Hazrat Ali Asghar Children Hospital. Razi J Med Sci Iran Univ Med Sci. 2003;10(36):535–539.
  • Mahzuni P, Moghaddam NA. Histopathological study of primary pediatric brain tumor from 1993 to 2003 in Isfahan. J Res Med Sci. 2006;11(3):203.
  • Mehrazin M, Yavari P. Morphological pattern and frequency of intracranial tumors in children. Childs Nerv Syst. 2007;23(2):157–162. doi:10.1007/s00381-006-0198-0. PMID: 16953459.
  • Mehrvar A, Faranoush M, Asl AAH, et al. Childhood central nervous system tumors at MAHAK's Pediatric Cancer Treatment and Research Center (MPCTRC), Tehran, Iran. Childs Nerv Syst. 2014;30(3):491–496. doi:10.1007/s00381-013-2256-8. PMID: 23943227.
  • Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica. 2007;114(2):97–109. doi:10.1007/s00401-007-0243-4. PMID: 17618441.
  • Grill J, Le Deley MC, Gambarelli D, et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 sources of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol. 2001;19(5):1288–1296. doi:10.1200/JCO.2001.19.5.1288. PMID: 11230470.
  • Marinoff A, Guo D, Ma C, et al. EPN-14 pediatric ependymoma: multi-institutional experience reveals poor long-term overall survival despite favorable five-source outcomes. Neuro Oncol. 2016;18(suppl 3):iii33. doi:10.1093/neuonc/now070.13.
  • Massimino M, Miceli R, Giangaspero F, et al. Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma. Neuro Oncol. 2016;18(10):1451–1460. doi:10.1093/neuonc/now108. PMID: 27194148.
  • Ahmed N, Bhurgri Y, Sadiq S, et al. Pediatric brain tumours at a tertiary care hospital in Karachi. Asian Pac J Cancer Prev. 2007;8(3):399–404. PMID: 18159977.
  • Korshunov A, Golanov A, Sycheva R, et al. The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients. Cancer. 2004;100(6):1230–1237. doi:10.1002/cncr.20075. PMID: 15022291.
  • Andrade FG, de Aguiar PH, Matushita H, et al. IntracranIal and spinal ependymoma. Arq Neuropsiquiatr. 2009;67(3A):626–632. doi:10.1590/S0004-282X2009000400010. PMID: 19722039.
  • Ezzat S, Kamal M, El-Khateeb N, et al. Pediatric brain tumors in a low/middle income country: does it differ from that in developed world? J Neurooncol. 2016;126(2):371–376. doi:10.1007/s11060-015-1979-7. PMID: 26514358.
  • Houjami M, Sahraoui S, Benchakroun N, et al. Intracranial ependymomas: retrospective study of 16 cases (translation). Cancer/Radiothérapie. 2011;15(2):136–139. doi:10.1016/j.canrad.2010.09.001.
  • Ho DMT, Hsu CY, Wong TT, et al. A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma. J Neurooncol. 2001;54(1):77–85. doi:10.1023/A:1012590505236. PMID: 11763426.
  • Ostrom QT, Gittleman H, de Blank PM, et al. American Brain Tumor Association adolescent and young adult primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 2016;18(suppl 1):i1–i50. doi:10.1093/neuonc/nov297. PMID: 26705298.
  • Burger PC. Atlas of tumor pathology: tumors of the central nervous system. 2000.
  • Ellison DW, Kocak M, Figarella-Branger D, et al. Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. J Negative Results Biomed. 2011;10(1):7. doi:10.1186/1477-5751-10-7.
  • Taylor RE. Review of radiotherapy dose and volume for intracranial ependymoma. Pediatr Blood Cancer. 2004;42(5):457–460. doi:10.1002/pbc.10470. PMID: 15049020.
  • Paulino AC, Wen BC. The significance of radiotherapy treatment duration in intracranial ependymoma. Int J Radiat Oncol Biol Phys. 2000;47(3):585–589. doi:10.1016/S0360-3016(99)00535-0. PMID: 10837939.
  • Chemotherapy for Ependymomas in Children: International Society for Pediatric Neurosurgery. Available at: https://www.ispn.guide/tumors-of-the-nervous-system-in-children/chemotherapy-for-tumors-in-the-nervous-system-of-children-homepage/management-with-chemotherapy-of-tumors-in-the-nervous-system-of-children/chemotherapy-for-ependymomas-in-children/.
  • Merchant TE, Fouladi M. Ependymoma: new therapeutic approaches including radiation and chemotherapy. J Neurooncol. 2005;75(3):287–299. doi:10.1007/s11060-005-6753-9. PMID: 16195801.
  • Wright KD, Gajjar A. New chemotherapy strategies and biological agents in the treatment of childhood ependymoma. Childs Nerv Syst. 2009;25(10):1275–1282. doi:10.1007/s00381-009-0809-7. PMID: 19212772.
  • Pollack IF, Gerszten PC, Martinez AJ, et al. Intracranial ependymomas of childhood: long‐term outcome and prognostic factors. Neurosurgery. 1995;37(4):655–667. doi:10.1227/00006123-199510000-00008. PMID: 8559293.
  • Boop FA. Repeat surgery for residual ependymoma. J Neurosurg Pediatr. 2011;8(3):244. doi:10.3171/2011.5.PEDS11173. PMID: 21882913.
  • Massimino M, Solero CL, Garrè ML, et al. Second-look surgery for ependymoma: the Italian experience. J Neurosurg: Pediatr. 2011;8(3):246–250. PMID: 21882914.
  • Van Poppel M, Klimo Jr P, Dewire M, et al. Resection of infantile brain tumors after neoadjuvant chemotherapy: the St. Jude experience. J Neurosurg: Pediatr. 2011;8(3):251–256. PMID: 21882915.
  • Sanford RA, Merchant TE, Zwienenberg-Lee M, et al. Advances in surgical techniques for resection of childhood cerebellopontine angle ependymomas are key to survival. Child's Nervous Syst. 2009;25(10):1229–1240. doi:10.1007/s00381-009-0886-7.
  • Qaddoumi I, Musharbash A, Elayyan M, et al. Closing the survival gap: Implementation of medulloblastoma protocols in a low‐income country through a twinning program. Int J Cancer. 2008;122(6):1203–1206. doi:10.1002/ijc.23160. PMID: 17985345.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.